Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer

par Obermayr, Eva, Agreiter, Christiane, Schuster, Eva, Fabikan, Hannah, Weinlinger, Christoph, Baluchova, Katarina, Hamilton, Gerhard, Hochmair, Maximilian, Zeillinger, Robert
Publié dans Cells (2019)

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients

par Hackner, Klaus, Buder, Anna, Hochmair, Maximilian J, Strieder, Matthaeus, Grech, Christina, Fabikan, Hannah, Burghuber, Otto C., Errhalt, Peter, Filipits, Martin
Publié dans Clin Med Insights Oncol (2021)

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis

par Hochmair, Maximilian J., Fabikan, Hannah, Illini, Oliver, Weinlinger, Christoph, Setinek, Ulrike, Krenbek, Dagmar, Prosch, Helmut, Rauter, Markus, Schumacher, Michael, Wöll, Ewald, Wass, Romana, Brehm, Elmar, Absenger, Gudrun, Bundalo, Tatjana, Errhalt, Peter, Urban, Matthias, Valipour, Arschang
Publié dans Pharmaceuticals (Basel) (2020)

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

par Illini, Oliver, Hochmair, Maximilian Johannes, Fabikan, Hannah, Weinlinger, Christoph, Tufman, Amanda, Swalduz, Aurélie, Lamberg, Kristina, Hashemi, Sayed M. S., Huemer, Florian, Vikström, Anders, Wermke, Martin, Absenger, Gudrun, Addeo, Alfredo, Banerji, Shantanu, Calles, Antonio, Clarke, Stephen, Di Maio, Massimo, Durand, Alice, Duruisseaux, Michaël, Itchins, Malinda, Kääränien, Okko-Sakari, Krenn, Florian, Laack, Eckart, de Langen, Adrianus Johannes, Mohorcic, Katja, Pall, Georg, Passaro, Antonio, Prager, Gerald, Rittmeyer, Achim, Rothenstein, Jeffrey, Schumacher, Michael, Wöll, Ewald, Valipour, Arschang
Publié dans Ther Adv Med Oncol (2021)